In a new study, researchers found people with clinically active systemic lupus erythematosus (SLE) disease on standard of care can attain or achieve low disease activity (LLDAS) and meet the ...

Chronic kidney disease (CKD) is a frequent contemporary concern and a major cause of death among patients in the United States with systemic lupus erythematosus (SLE).

In vivo CD19 CAR T-cell therapy showed promising results in a feasibility study of five patients with refractory systemic ...

Active LN and the presence of U1-RNP antibodies were linked to low BMD and osteoporosis among patients with SLE.

Objective Organ damage is a key determinant of poor prognosis and increased mortality in systemic lupus erythematosus (SLE).

Introduction SLE is a chronic autoimmune disease characterised by multisystem involvement and fluctuating clinical course, ...

The autoimmune disease lupus, which affects mainly women, can have wide-ranging impacts on health and quality of life.

An interim analysis of the TULIP-SC trial found that weekly subcutaneous delivery of Saphnelo significantly reduced disease activity in patients with moderate to severe SLE, offering a more convenient ...

Systemic lupus erythematosus (SLE) is a chronic autoimmune disorder that predisposes affected individuals to an elevated risk of cardiovascular disease (CVD). The intricate interplay of traditional ...

Patients with interstitial lung disease in systemic sclerosis demonstrate distinct intestinal microbiota that may help identify pathogenesis and targeted treatments, according to data published in ...

Objective Breastfeeding prevalence and challenges among women of systemic lupus erythematosus (SLE) and rheumatoid arthritis ...